Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladislav Pecen

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
International Journal of Cardiology|June 24, 2020
Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategiesGiuseppe Patti, Ladislav Pecen, Marius Constantin Manu, et al.
In Vivo (Athens, Greece)|April 24, 2012
heterogeneity of dna ploidy in endometrial carcinoma: comparison of different tissue samples obtained during diagnosis and treatmentPavla Libalova, Zdenka Vernerova, Lucie Hubickova-Heringova, et al.
International Journal of Analytical Chemistry|February 26, 2026
Quantification of 24,25-Dihydroxyvitamin D<sub>3</sub> in Serum Using LC-MS/MS With Derivatization and Lipid-Removal FiltrationMarta Studecká, Eliška Fousková, Josefa Provalilová, et al.
Heart (British Cardiac Society)|February 24, 2017
Gender differences in clinical presentation and 1-year outcomes in atrial fibrillationRenate B Schnabel, Ladislav Pecen, Francisco M Ojeda, et al.
Anticancer Research|October 1, 2021
The Role of Serum Tumor Markers in Follow-up After Surgical Treatment of Malignant Lung TumorsJosef Vodicka, Martin Skala, Jakub Sebek, et al.
Neurosurgical Review|May 23, 2023
Role of risk factors, scoring systems, and prognostic models in predicting the functional outcome in meningioma surgery: multicentric study of 552 skull base meningiomasMichaela May, Vojtech Sedlak, Ladislav Pecen, et al.
Journal of Clinical Medicine|March 11, 2023
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF ProgramTze-Fan Chao, Martin Unverdorben, Paulus Kirchhof, et al.
Anticancer Research|September 21, 2012
Carotid intima-media thickness and laboratory parameters of atherosclerosis risk in patients with breast cancerBohuslav Melichar, Hana Kalábová, Leoš Ungermann, et al.
International Journal of Cardiology|September 18, 2018
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registriesGiuseppe Patti, Ladislav Pecen, Markus Lucerna, et al.
Clinical Cardiology|February 27, 2025
Two-Year Follow-Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA-AF ProgramRaffaele De Caterina, Martin Unverdorben, Cathy Chen, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
International Journal of Cardiology|June 24, 2020
Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategiesGiuseppe Patti, Ladislav Pecen, Marius Constantin Manu, et al.
In Vivo (Athens, Greece)|April 24, 2012
heterogeneity of dna ploidy in endometrial carcinoma: comparison of different tissue samples obtained during diagnosis and treatmentPavla Libalova, Zdenka Vernerova, Lucie Hubickova-Heringova, et al.
International Journal of Analytical Chemistry|February 26, 2026
Quantification of 24,25-Dihydroxyvitamin D<sub>3</sub> in Serum Using LC-MS/MS With Derivatization and Lipid-Removal FiltrationMarta Studecká, Eliška Fousková, Josefa Provalilová, et al.
Heart (British Cardiac Society)|February 24, 2017
Gender differences in clinical presentation and 1-year outcomes in atrial fibrillationRenate B Schnabel, Ladislav Pecen, Francisco M Ojeda, et al.
Anticancer Research|October 1, 2021
The Role of Serum Tumor Markers in Follow-up After Surgical Treatment of Malignant Lung TumorsJosef Vodicka, Martin Skala, Jakub Sebek, et al.
Neurosurgical Review|May 23, 2023
Role of risk factors, scoring systems, and prognostic models in predicting the functional outcome in meningioma surgery: multicentric study of 552 skull base meningiomasMichaela May, Vojtech Sedlak, Ladislav Pecen, et al.
Journal of Clinical Medicine|March 11, 2023
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF ProgramTze-Fan Chao, Martin Unverdorben, Paulus Kirchhof, et al.
Anticancer Research|September 21, 2012
Carotid intima-media thickness and laboratory parameters of atherosclerosis risk in patients with breast cancerBohuslav Melichar, Hana Kalábová, Leoš Ungermann, et al.
International Journal of Cardiology|September 18, 2018
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registriesGiuseppe Patti, Ladislav Pecen, Markus Lucerna, et al.
Clinical Cardiology|February 27, 2025
Two-Year Follow-Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA-AF ProgramRaffaele De Caterina, Martin Unverdorben, Cathy Chen, et al.
Pageof 9